| 1 | = | Malignant Breast Neoplasm | 200,691 | 100 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 1639
- siteDefinition
- USCS "Female Breast" (ICD-10 C50; ICD-O-3 C500-C509)
ranking row 2593416 |
| 2 | = | Malignant Lung Neoplasm | 88,231 | 96.4 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 3727
- siteDefinition
- USCS "Lung and Bronchus" (ICD-10 C34; ICD-O-3 C340-C349)
ranking row 2593417 |
| 3 | = | Malignant Colon Neoplasm | 57,351 | 92.9 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 823
- siteDefinition
- USCS "Colon excluding Rectum" (ICD-10 C18, C26.0; ICD-O-3 C180-C189, C260)
ranking row 2593418 |
| 4 | = | Malignant Uterine Corpus Neoplasm | 35,995 | 89.3 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 1129
- siteDefinition
- USCS "Corpus" (ICD-10 C54; ICD-O-3 C540-C549)
ranking row 2593419 |
| 5 | = | Non-Hodgkin Lymphoma | 25,965 | 85.7 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 5257
- siteDefinition
- USCS "Non-Hodgkin Lymphoma" (ICD-10 C82-C85, C96.3; ICD-O-3 histology 9590-9597, 9670-9729, 9735, 9737-9738 (+9811-9818, 9823, 9827, 9837 outside marrow/blood))
ranking row 2593420 |
| 6 | = | Cutaneous Melanoma | 21,557 | 82.1 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 4033
- siteDefinition
- USCS "Melanomas of the Skin" (ICD-10 C43; ICD-O-3 C440-C449 with histology 8720-8790)
ranking row 2593421 |
| 7 | = | Malignant Ovarian Neoplasm | 21,506 | 78.6 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 5563
- siteDefinition
- USCS "Ovary" (ICD-10 C56; ICD-O-3 C569)
ranking row 2593422 |
| 8 | = | Malignant Thyroid Gland Neoplasm | 18,248 | 75 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 6991
- siteDefinition
- USCS "Thyroid" (ICD-10 C73; ICD-O-3 C739)
ranking row 2593423 |
| 9 | = | Malignant Rectal Neoplasm | 17,638 | 71.4 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 6073
- siteDefinition
- USCS "Rectum and Rectosigmoid Junction" (ICD-10 C19-C20; ICD-O-3 C199, C209)
ranking row 2593424 |
| 10 | = | Leukemia | 16,086 | 67.9 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 3115
- siteDefinition
- USCS "Leukemias" (ICD-10 C91-C95 (leukemia recodes; C90.1 plasma cell leukemia included by SEER); ICD-O-3 leukemia histologies 9733-9948 per SEER site recode)
ranking row 2593425 |
| 11 | = | Malignant Pancreatic Neoplasm | 16,078 | 64.3 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 5767
- siteDefinition
- USCS "Pancreas" (ICD-10 C25; ICD-O-3 C250-C259)
ranking row 2593426 |
| 12 | = | Malignant Bladder Neoplasm | 15,727 | 60.7 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 7297
- siteDefinition
- USCS "Urinary Bladder" (ICD-10 C67; ICD-O-3 C670-C679)
ranking row 2593427 |
| 13 | = | Malignant Kidney Neoplasm | 15,020 | 57.1 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 2503
- siteDefinition
- USCS "Kidney and Renal Pelvis" (ICD-10 C64-C65; ICD-O-3 C649, C659)
ranking row 2593428 |
| 14 | = | Malignant Cervical Neoplasm | 12,924 | 53.6 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 619
- siteDefinition
- USCS "Cervix" (ICD-10 C53; ICD-O-3 C530-C539)
ranking row 2593429 |
| 15 | = | Malignant Central Nervous System Neoplasm | 8,747 | 50 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 313
- siteDefinition
- USCS "Brain and Other Nervous System" (ICD-10 C70, C71, C72; ICD-O-3 C700-C709, C710-C719, C720-C729)
ranking row 2593430 |
| 16 | = | Malignant Gastric Neoplasm | 8,024 | 46.4 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 6685
- siteDefinition
- USCS "Stomach" (ICD-10 C16; ICD-O-3 C160-C169)
ranking row 2593431 |
| 17 | = | Multiple Myeloma | 7,763 | 42.9 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 4645
- siteDefinition
- USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734)
ranking row 2593432 |
| 18 | = | Malignant Liver Neoplasm | 4,689 | 39.3 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 3421
- siteDefinition
- USCS "Liver and Intrahepatic Bile Duct" (ICD-10 C22; ICD-O-3 C220-C221)
ranking row 2593433 |
| 19 | = | Hodgkin Lymphoma | 3,762 | 35.7 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 1741
- siteDefinition
- USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal))
ranking row 2593434 |
| 20 | = | Malignant Vulvar Neoplasm | 3,749 | 32.1 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 7807
- siteDefinition
- USCS "Vulva" (ICD-10 C51; ICD-O-3 C510-C519)
ranking row 2593435 |
| 21 | = | Malignant Esophageal Neoplasm | 3,285 | 28.6 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 1333
- siteDefinition
- USCS "Esophagus" (ICD-10 C15; ICD-O-3 C150-C159)
ranking row 2593436 |
| 22 | = | Malignant Anal Neoplasm | 2,485 | 25 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 7
- siteDefinition
- USCS "Anus, Anal Canal and Anorectum" (ICD-10 C21; ICD-O-3 C210-C212, C218)
ranking row 2593437 |
| 23 | = | Malignant Laryngeal Neoplasm | 2,395 | 21.4 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 2809
- siteDefinition
- USCS "Larynx" (ICD-10 C32; ICD-O-3 C320-C329)
ranking row 2593438 |
| 24 | = | Malignant Salivary Gland Neoplasm | 1,459 | 17.9 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 6379
- siteDefinition
- USCS "Salivary Gland" (ICD-10 C07-C08; ICD-O-3 C079-C089)
ranking row 2593439 |
| 25 | = | Malignant Vaginal Neoplasm | 1,188 | 14.3 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 7603
- siteDefinition
- USCS "Vagina" (ICD-10 C52; ICD-O-3 C529)
ranking row 2593440 |
| 26 | = | Malignant Mesothelioma | 638 | 10.7 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 4339
- siteDefinition
- USCS "Mesothelioma" (ICD-10 C45; ICD-O-3 histology 9050-9055 (any site))
ranking row 2593441 |
| 27 | = | Malignant Nasopharyngeal Neoplasm | 503 | 7.1 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 4951
- siteDefinition
- USCS "Nasopharynx" (ICD-10 C11; ICD-O-3 C110-C119)
ranking row 2593442 |
| 28 | = | Malignant Hypopharyngeal Neoplasm | 481 | 3.6 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 2047
- siteDefinition
- USCS "Hypopharynx" (ICD-10 C12-C13; ICD-O-3 C129, C130-C139)
ranking row 2593443 |
| 29 | = | Kaposi Sarcoma | 167 | 0 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 2353
- siteDefinition
- USCS "Kaposi Sarcoma" (ICD-10 C46; ICD-O-3 histology 9140 (any site))
ranking row 2593444 |